OTCMKTS:KTYCF Kits Eyecare (KTYCF) Stock Price, News & Analysis → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free KTYCF Stock Alerts $4.02 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$4.02▼$4.0250-Day Range$4.02▼$4.9352-Week Range$3.14▼$4.93VolumeN/AAverage Volume865 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Kits Eyecare alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Kits Eyecare Stock (OTCMKTS:KTYCF)Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada. It manufactures progressive and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. The company operates through a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. Kits Eyecare Ltd. was founded in 2002 and is headquartered in Vancouver, Canada.Read More KTYCF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KTYCF Stock News HeadlinesApril 23, 2024 | finance.yahoo.comKITS Eyecare Sets First Quarter 2024 Conference Call for Wednesday, May 8, 2024, at 9:00 a.m. ETApril 19, 2024 | americanbankingnews.comKits Eyecare (OTCMKTS:KTYCF) Trading Down 0.8%April 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.April 16, 2024 | finance.yahoo.comKITS Eyecare Hires Two Key Senior Finance LeadersApril 10, 2024 | finance.yahoo.comKITS Eyecare Announces Sabrina Liak will Transition to Senior Advisor Role and Continue as Board MemberApril 10, 2024 | finance.yahoo.comPleasing Signs As A Number Of Insiders Buy Kits Eyecare StockApril 4, 2024 | finance.yahoo.comKITS Eyecare Reports Preliminary First Quarter 2024 ResultsApril 2, 2024 | finance.yahoo.comKITS Eyecare to Present at the LD Micro Invitational XIVApril 26, 2024 | Weiss Ratings (Ad)The Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.April 1, 2024 | msn.comOphthalmologists provide complex eye care: When to see one and what to expectMarch 18, 2024 | finance.yahoo.comKITS Eyecare Names Zhe Choo Chief Financial OfficerMarch 12, 2024 | finance.yahoo.comKITS Eyecare to Participate in the 36th Annual ROTH Conference on March 18, 2024March 6, 2024 | finance.yahoo.comKITS Eyecare Reports Fourth Quarter and Full Year 2023 ResultsFebruary 28, 2024 | msn.comInvestor Alert - KITS Eyecare: Revolutionizing Digital Eyecare with Cutting-Edge Technology and Rapid GrowthFebruary 27, 2024 | msn.comEye ointments sold nationwide at Walmart and CVS recalled due to infection riskFebruary 20, 2024 | finance.yahoo.comKITS Eyecare Sets Fourth Quarter and Full Year 2023 Conference Call for Wednesday, March 6, 2024, at 9:00 a.m. ETJanuary 29, 2024 | finance.yahoo.comKITS Eyecare Welcomes Jean Francois Jupille as Director of User ExperienceJanuary 12, 2024 | finance.yahoo.comKITS Eyecare to Present at the 26th Annual Needham Growth Conference on January 16, 2024December 15, 2023 | finance.yahoo.comVIDEO - KITS Eyecare: Revolutionizing Digital Eyecare with Cutting-Edge Technology and Rapid Growth BTV Investor AlertNovember 29, 2023 | finance.yahoo.comKITS Eyecare Announces Record Results for Cyber MondayNovember 21, 2023 | finance.yahoo.comKITS Eyecare Announces Record Eyeglasses Revenue in Week Leading into Black FridayNovember 15, 2023 | finance.yahoo.comKITS Eyecare to Attend the 3rd Annual Needham Consumer Tech and E-Commerce Virtual Conference on November 20thNovember 9, 2023 | msn.comKits Eyecare GAAP EPS of $0.01, revenue of $31.2MNovember 8, 2023 | finance.yahoo.comKITS Eyecare Reports Record Third Quarter 2023 Financial ResultsNovember 8, 2023 | morningstar.comKits Eyecare Ltd Ordinary Shares KITSOctober 25, 2023 | finance.yahoo.comKITS Eyecare Sets Third Quarter 2023 Conference Call for Wednesday, November 8, 2023, at 9:00 a.m. ETOctober 11, 2023 | finance.yahoo.comKITS Eyecare Expands Manufacturing Capacity of Digital Progressive Eyeglasses by 50%See More Headlines Receive KTYCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kits Eyecare and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Cyclical Industry Specialty Retail Sub-IndustryN/A Current SymbolOTCMKTS:KTYCF CUSIPN/A CIKN/A Webwww.kits.com Phone800-487-5487FaxN/AEmployees143Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Roger V. Hardy (Age 55)Co-Founder, CEO & Chairman of the Board Comp: $345.53kMs. Sabrina Liak (Age 44)Co-Founder, President, Corporate Secretary & Director Comp: $307.89kMr. Joseph ThompsonCo-Founder & COOMr. Arshil AbdullaChief Technology OfficerMr. Robert LongC.M.O.Ms. Zhe Choo C.A.CPA, Chief Financial OfficerMr. Tai SilveyChief Business Development OfficerMr. Ibrahim KamarSenior Vice President of FinanceAllen ZhuControllerMore ExecutivesKey CompetitorsAlcannaOTCMKTS:LQSIFAlimentation Couche-TardOTCMKTS:ANCTFArkoNASDAQ:ARKOWAvoltaOTCMKTS:DFRYFCanadian TireOTCMKTS:CDNTFView All Competitors KTYCF Stock Analysis - Frequently Asked Questions How have KTYCF shares performed in 2024? Kits Eyecare's stock was trading at $4.5776 at the beginning of 2024. Since then, KTYCF shares have decreased by 12.2% and is now trading at $4.02. View the best growth stocks for 2024 here. Are investors shorting Kits Eyecare? Kits Eyecare saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 700 shares, a decline of 41.7% from the February 29th total of 1,200 shares. Based on an average trading volume of 2,300 shares, the days-to-cover ratio is currently 0.3 days. View Kits Eyecare's Short Interest. How do I buy shares of Kits Eyecare? Shares of KTYCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:KTYCF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsTrump is sounding the alarmPreserve GoldJim Cramer’s “The Biggest Drug Ever”Behind the MarketsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kits Eyecare Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
